User:Mr. Ibrahem/Anakinra

Anakinra, sold under the brand name Kineret, is a medication used to treat rheumatoid arthritis, cryopyrin-associated periodic syndromes, familial Mediterranean fever, and Still's disease. It is also used in people with COVID-19 who require oxygen therapy. It is given by injection under the skin.

Common side effects include pain at the site of injection, upper respiratory tract infection, headache, nausea, joint pain, and fever. Other side effects may include anaphylaxis. Safety in pregnancy is unclear. It is a recombinant version of the interleukin 1 receptor antagonist protein which blocks the effects of interleukin 1.

Anakinra was approved for medical use in the United States in 2001 and Europe in 2002. In the United Kingdom a week of medication costs the NHS about £180 as of 2021. This amount in the United States costs about 1,250 USD.